These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8915311)

  • 1. Usefulness of screening investigations in neurofibromatosis type 1. A study of 152 patients.
    Wolkenstein P; Frèche B; Zeller J; Revuz J
    Arch Dermatol; 1996 Nov; 132(11):1333-6. PubMed ID: 8915311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological complications involving the central nervous system in neurofibromatosis type 1.
    Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
    Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of systematic brain magnetic resonance imaging in children with neurofibromatosis type 1].
    Blanchard G; Pinson S; Rousselle C; Lorthois S; Combemale P; Bernard M; Lion Francois L
    Arch Pediatr; 2009 Dec; 16(12):1527-32. PubMed ID: 19864117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Managing children with neurofibromatosis type 1: what should we look for?].
    Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
    Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of patients attending a neurofibromatosis type 1 clinic.
    Noble F; Kornberg AJ; Elder JE; Delatycki MB
    J Paediatr Child Health; 2007; 43(1-2):55-9. PubMed ID: 17207057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.
    Nunley KS; Gao F; Albers AC; Bayliss SJ; Gutmann DH
    Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurofibromatosis type 1: a survey of 195 patients].
    Overweg-Plandsoen WC; Weersink RG; Sillevis Smitt JH; Fleury P; van Asperen CJ
    Ned Tijdschr Geneeskd; 1997 Mar; 141(13):624-9. PubMed ID: 9127578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral arteriopathy in children with neurofibromatosis type 1.
    Rea D; Brandsema JF; Armstrong D; Parkin PC; deVeber G; MacGregor D; Logan WJ; Askalan R
    Pediatrics; 2009 Sep; 124(3):e476-83. PubMed ID: 19706560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choroidal abnormalities detected by near-infrared reflectance imaging as a new diagnostic criterion for neurofibromatosis 1.
    Viola F; Villani E; Natacci F; Selicorni A; Melloni G; Vezzola D; Barteselli G; Mapelli C; Pirondini C; Ratiglia R
    Ophthalmology; 2012 Feb; 119(2):369-75. PubMed ID: 21963267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype.
    Pasmant E; Sabbagh A; Hanna N; Masliah-Planchon J; Jolly E; Goussard P; Ballerini P; Cartault F; Barbarot S; Landman-Parker J; Soufir N; Parfait B; Vidaud M; Wolkenstein P; Vidaud D; France RN
    J Med Genet; 2009 Jul; 46(7):425-30. PubMed ID: 19366998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and genetic significance of unilateral Lisch nodules.
    Ceuterick SD; Van Den Ende JJ; Smets RM
    Bull Soc Belge Ophtalmol; 2005; (295):49-53. PubMed ID: 15849989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
    Thiagalingam S; Flaherty M; Billson F; North K
    Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Segmental neurofibromatosis in children. Presentation of 43 patients].
    Pascual-Castroviejo I; Pascual-Pascual SI; Velázquez-Fragua R; Viaño J; López-Gutiérrez JC
    Rev Neurol; 2008 Oct 16-31; 47(8):399-403. PubMed ID: 18937200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neurofibromatosis in children. Our experience].
    López-Pisón J; Cuadrado-Martín M; Boldova-Aguar MC; Muñoz-Mellado A; Cabrerizo de Diago R; Peña-Segura JL
    Rev Neurol; 2003 Nov 1-15; 37(9):820-5. PubMed ID: 14606048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological study of neurofibromatosis type 1: an experience in Nigeria.
    Odebode TO; Afolayan EA; Adigun IA; Daramola OO
    Int J Dermatol; 2005 Feb; 44(2):116-20. PubMed ID: 15689208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Difficulties of the management of head and neck neurofibromatosis].
    Jeblaoui Y; Neji B; Haddad S; Mnif D; Hchicha S
    Ann Chir Plast Esthet; 2007 Feb; 52(1):43-50. PubMed ID: 17137698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Optic pathway gliomas in patients with neurofibromatosis type 1: clinical-neuroradiological integrated approach].
    Zuccoli G; Ferrozzi F; Signorini M; Virdis R; Troiso A
    Radiol Med; 2001 May; 101(5):382-5. PubMed ID: 11438792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical study of type 1 neurofibromatosis in north west England.
    McGaughran JM; Harris DI; Donnai D; Teare D; MacLeod R; Westerbeek R; Kingston H; Super M; Harris R; Evans DG
    J Med Genet; 1999 Mar; 36(3):197-203. PubMed ID: 10204844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ki-67 proliferation-index (MIB-1) of neurofibromas in neurofibromatosis type 1 patients.
    Friedrich RE; Hagel C; Brehme Z; Kluwe L; Mautner VF
    Anticancer Res; 2003; 23(2A):953-5. PubMed ID: 12820329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients.
    Leroy K; Dumas V; Martin-Garcia N; Falzone MC; Voisin MC; Wechsler J; Revuz J; Créange A; Levy E; Lantieri L; Zeller J; Wolkenstein P
    Arch Dermatol; 2001 Jul; 137(7):908-13. PubMed ID: 11453810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.